BRCA1/2-deficient cancers presented with a significantly higher TMB than CHEK2-deficient cancers (median TMB of 3.72 [range = 1.67-22.27 variants/Megabase]; P < .02; Figure 1, C). Here, BRCA1 is linked to cancer.